Vor BioPharma（VOR.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

机构投资者62.62%
风投/私募35.06%
个人与内部人士2.00%
公众及其他0.32%

主要股东

主要股东最新
股东
FMR LLC	12.01%	651.00 万	9.17%	+497.03 万	2026/07/31
TCG Crossover Management, LLC	9.59%	567.31 万	--	+567.31 万	2026/03/31
RA Capital Management, L.P.	7.61%	450.19 万	2.37%	-90.31 万	2026/07/16
Forbion Capital Partners B.V.	6.96%	411.74 万	2.38%	+50.00 万	2026/03/31
BlackRock, Inc.	5.86%	346.81 万	4.40%	+267.33 万	2026/06/30
VERVE CAPITAL, Inc.	5.77%	341.09 万	--	+341.09 万	2026/06/30
VR Management, LLC	5.14%	304.17 万	0.12%	+109.80 万	2026/03/31
State Street Investment Management	4.42%	261.63 万	2.36%	+149.79 万	2026/06/30
Frazier Life Sciences Management, LP	4.30%	254.39 万	2.27%	+0	2026/03/31
Vanguard Capital Management, LLC	4.03%	238.50 万	1.04%	+76.62 万	2026/06/30
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	3.38%	199.99 万	1.78%	+0	2026/03/31
Caligan Partners, LP	3.25%	192.51 万	0.86%	+100.00 万	2026/03/31
Great Point Partners, LLC	2.96%	175.00 万	0.58%	+37.99 万	2026/03/31
Paradigm Biocapital Advisors LP	2.96%	175.00 万	1.56%	+0	2026/03/31
Reid Hoffman	1.97%	116.69 万	1.04%	+0	2025/10/21
Geode Capital Management, LLC	1.80%	106.25 万	1.16%	+71.99 万	2026/06/30
Nextbio Capital Management LP	1.69%	100.00 万	0.89%	+0	2026/03/31
Logos Global Management, L.P.	1.27%	75.00 万	1.01%	+65.00 万	2026/03/31
Rosalind Advisors, Inc.	1.18%	70.00 万	--	+70.00 万	2026/03/31
Nan Fung Trinity (HK) Limited	1.09%	64.66 万	--	+64.66 万	2026/06/30